References
- Harrison L I, Donnell D, Simmons J L. Twenty-eight day double-blind study of an HFA-134a inhalation aerosol system in healthy subjects. J Pharm Pharmacol 1996; 48: 596
- United States Pharmacopeial Convention. Dosage unit sampling for metered-dose inhalers. Pharmacopeial Forum 1998; 24: 6940
- Jacobson K, Kane R E, Banerji D, Azmacort H FA, Group Clinical Study. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Ann Allergy Asthma Immunol 1999; 83: 327
- Welch M, Kane R E, Donald Banerji D, Azmacort® H FA, Group Study. Triamcinolone acetonide inhalation aerosol in the treatment of moderate persistent asthma; comparison of products using a chlorofluorocarbon and a non-chlorofluorocarbon propellant. Chest 1999; 226: 1304
- Klein B EK, Klein R, Linton K LP. Prevalence of age-related lens opacities in a population. The Beaver Dam Study. Ophthalmology 1992; 99: 546
- Sperduto R D, Seigel D. Senile lens and senile macular changes in a population-based sample. Am J Ophthalmol 1980; 90: 86
- Weale R A. Inter-ethnic risk ratios for different types of cataract. Ophthalmol Res 1995; 27: 214
- Urban RC, Jr, Cotlier E. Corticosteroid-induced cataracts. Surv Ophthalmol 1986; 31: 102
- Cumming R G, Mithcel P, Leeder S R. Use of inhaled corticosteroids and the risk of cataract. N Engl J Med 1997; 337: 8
- Garbe E, Suissa S, LeLorier J. Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA 1998; 280: 539